A novel antagonist of the canonical Wnt-signalling pathway, Sostdc1, is expressed in experimental models of myeloma and suppresses bone formation
Keyword(s):
Keyword(s):
2011 ◽
Vol 36
(5)
◽
pp. 534-540
◽
Keyword(s):
2014 ◽
Vol 39
(3)
◽
pp. 368-375
◽
Keyword(s):
Keyword(s):
Keyword(s):